Kemal Malik’s Keynote

Kemal Malik, Board Member for Innovation at Bayer, opened Health 2.0 Europe 2014 with an examination of drug development using Health 2.0 technologies. By demystifying the process of drug innovation, Kemal explained how entrepreneurs and startups can become a part of creating new medicines and contribute to making current treatments better.